We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

November 10, 2009

REID v. HEMISPHERX BIOPHARMA, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 15, 2011

    $3.6M Hemispherx Securities Settlement Gets Final OK

    A federal judge has given final approval to a $3.6 million settlement between Hemispherx Biopharma Inc. and a class of plaintiffs who alleged the company misled investors on the approval status of chronic fatigue syndrome drug Ampligen.


Parties

To view the parties, register now.